Anti-Human DLL4 Recombinant Antibody(Demcizumab)

Name: Anti-Human DLL4 Recombinant Antibody(Demcizumab)
Brand: KMD Bioscience
SKU: YR1276

YR1276

科研级 Demcizumab ( 登赛珠单抗 ), Anti-DLL4 Recombinant Antibody, Research Grade Demcizumab

DATASHEET MSDS

Product Description

Alias	科研级 Demcizumab ( 登赛珠单抗 ), Anti-DLL4 Recombinant Antibody, Research Grade Demcizumab
Catalog Number	YR1276
Molecular Name	Demcizumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Demcizumab /dɛmˈsɪzʊmæb/ is a humanized monoclonal antibody which is used to treat patients with pancreatic cancer or non-small cell lung cancer. Demcizumab has completed phase 1 trials and is currently undergoing phase 2 trials. Demcizumab was developed by OncoMed Pharmaceuticals in collaboration with Celgene.
CAS Number	1243262-17-0
Application	ELISA, FCM, IP, FuncS, IF, Neut, WB
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	DLL4[Homo sapiens]

Login